Heron Therapeutics, Inc.
NASDAQ:HRTXBiotechnology
Healthcare
$0.26 +3.74%
+$0.01 today
- Market cap
- $50.25M
- Beta
- 1.57
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$0.16
52W Low $0.38High $2.30
Volume 3.60M
Average 2.90M
Price history
Heron Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-75.08%
Period high
$1.49
Period low
$0.26
Latest
$0.26
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| DEFA14A | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| DEFA14A | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| S-8 | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 8-K | Sep 29, 2026 | Sep 29, 2026 |
Competitors
Who does Heron Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about HRTX's filings, answered from its disclosures.
What is the latest HRTX filing?
The latest filing shown is 4 dated Nov 10, 2026.
How many recent filings does HRTX have?
Intrinsic Alpha currently shows 20 recent filings for HRTX.
Continue the stock analysis
Jump to another research area for this company.